methylphenidate hydrochloride
Generic: methylphenidate hydrochloride
Labeler: actavis pharma, inc.Drug Facts
Product Profile
Brand Name
methylphenidate hydrochloride
Generic Name
methylphenidate hydrochloride
Labeler
actavis pharma, inc.
Dosage Form
CAPSULE, EXTENDED RELEASE
Routes
Active Ingredients
methylphenidate hydrochloride 30 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0591-3873
Product ID
0591-3873_1895894a-ed70-4f82-b512-6bc184ee806c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA208861
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2020-09-30
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05913873
Hyphenated Format
0591-3873
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
methylphenidate hydrochloride (source: ndc)
Generic Name
methylphenidate hydrochloride (source: ndc)
Application Number
ANDA208861 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 30 mg/1
Packaging
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0591-3873-19)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1895894a-ed70-4f82-b512-6bc184ee806c", "openfda": {"unii": ["4B3SC438HI"], "rxcui": ["1648183", "1806200", "1806202", "1806204", "1806206", "1806208", "1806210"], "spl_set_id": ["ecbb4a30-21ac-42e1-b4e9-6c35344ffc45"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0591-3873-19)", "package_ndc": "0591-3873-19", "marketing_start_date": "20200930"}], "brand_name": "methylphenidate hydrochloride", "product_id": "0591-3873_1895894a-ed70-4f82-b512-6bc184ee806c", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "0591-3873", "dea_schedule": "CII", "generic_name": "methylphenidate hydrochloride", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "methylphenidate hydrochloride", "active_ingredients": [{"name": "METHYLPHENIDATE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "ANDA208861", "marketing_category": "ANDA", "marketing_start_date": "20200930", "listing_expiration_date": "20261231"}